End Stage Liver DIsease
94
15
16
39
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.5%
8 terminated out of 94 trials
83.0%
-3.5% vs benchmark
11%
10 trials in Phase 3/4
23%
9 of 39 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 39 completed trials
Clinical Trials (94)
Disparities Among Liver Transplant Patients
Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
Immune Tolerance Induction After Liver Transplantation
Quantitative Liver Function Tests Using Cholates
Tocotrienol Against the Progression of End Stage Liver Disease
Single-Cell and Spatial Transcriptomics Analysis of Steatotic Donor Liver Susceptibility to Post-Transplant Injury
Functional Assessment in Liver Transplantation
Pilot Study of the Liver Live Donor Champion Program
Growth Hormone in Decompensated Liver Cirrhosis
Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)
A Study of SIPLIZUMAB in AILD and LT Patients
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
Longitudinal Study of Mitochondrial Hepatopathies
Angiotensin 2 for AKI After OLT
Adverse Outcomes and Mortality in Liver Transplant
Adding Specialist Palliative Care to Transplantation Pilot Trial
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease